# Tandem Diabetes Care, Inc. (TNDM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TNDM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 247.22M | $ -20.39M | $ 4.79M | $ 734.74M | $ 132.40M |
| 2025 | $ 1.04B | $ -209.61M | $ -30.38M | $ 564.34M | $ 155.17M |
| 2024 | $ 1.11B | $ -100.93M | $ 5.25M | $ 473.57M | $ 263.10M |
| 2023 | $ 808.47M | $ -240.70M | $ -90.19M | $ 415.67M | $ 313.63M |
| 2022 | $ 895.04M | $ -105.67M | $ 18.28M | $ 419.88M | $ 439.95M |
| 2021 | $ 835.38M | $ 18.50M | $ 104.42M | $ 314.67M | $ 433.11M |
| 2020 | $ 635.47M | $ -43.80M | $ -9.71M | $ 228.32M | $ 366.31M |
| 2019 | $ 467.65M | $ -31.95M | $ 28.87M | $ 20.38M | $ 194.98M |
| 2018 | $ 242.83M | $ -161.93M | $ -14.93M | $ 0 | $ 131.28M |
| 2017 | $ 144.95M | $ -98.38M | $ -96.80M | $ 76.54M | $ -29.15M |
| 2016 | $ 115.91M | $ -114.81M | $ -96.45M | $ 78.96M | $ -5.93M |
| 2015 | $ 102.28M | $ -101.68M | $ -90.70M | $ 29.67M | $ 63.47M |
| 2014 | $ 70.26M | $ -112.37M | $ -95.61M | $ 29.44M | $ 54.57M |
| 2013 | $ 41.25M | $ -89.80M | $ -76.47M | $ 29.40M | $ 115.54M |
| 2012 | $ 3.57M | $ -23.20M | $ -32.75M | $ 4.20M | $ -106.05M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 5.55 |
| Liabilities / Eq | 7.71 |
| Current Ratio | 3.58 |

## Other views

- [Metrics](https://sponda.capital/en/TNDM.md)
- [Charts](https://sponda.capital/en/TNDM/charts.md)
- [Compare](https://sponda.capital/en/TNDM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.